Ticker Scorecard - TSHA Basics Company: Taysha Gene Therapies, Inc. IPO Date: September 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $329.96M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 4.27% Avg Daily Range (30 D): $0.06 | 3.49% Avg Daily Range (90 D): $0.09 | 4.39% Institutional Daily Volume Avg Daily Volume: 1.18M Avg Daily Volume (30 D): 1.81M Avg Daily Volume (90 D): 2.94M Trade Size Avg Trade Size (Sh.): 217 Avg Trade Size (Sh.) (30 D): 253 Avg Trade Size (Sh.) (90 D): 282 Institutional Trades Total Inst.Trades: 255 Avg Inst. Trade: $2.11M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $2.07M Avg Inst. Trade Volume: .65M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.96M Avg Closing Trade (30 D): $.77M Avg Closing Trade (90 D): $1.41M Avg Closing Volume: 1.04M     News Feb 7, 2025 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Dec 6, 2024 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Oct 22, 2024 @ 12:00 PM Taysha Gene Therapies to Present Biodistribution D... Source: N/A Sep 6, 2024 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: N/A Jun 26, 2024 @ 1:14 PM Taysha Gene Therapies Announces Pricing of Public ... Source: Taysha Gene Therapies, Inc. Financials   TTM Q3 2024 Q2 2024 Basic EPS $.63 $-.1 $-.09 Diluted EPS $.63 $-.1 $-.09 Revenue $ 9.92M $ 1.79M $ 1.11M Gross Profit $ $ $ Net Income / Loss $ -22.77M $ -25.52M $ -20.93M Operating Income / Loss $ -87.77M $ -25.9M $ -21.3M Cost of Revenue $ $ $ Net Cash Flow $ -6.63M $ -15.06M $ 48.76M PE Ratio 2.63